Publicaciones (36) Publicaciones en las que ha participado algún/a investigador/a

2007

  1. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer

    World Journal of Gastroenterology, Vol. 13, Núm. 14, pp. 2135-2137

  2. Acquired nasopharyngeal stenosis: Surgical treatment for this unusual complication after chemoradiation for nasopharyngeal carcinoma

    Otolaryngology- Head and Neck Surgery, Vol. 137, Núm. 6, pp. 959-961

  3. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy

    Annals of Surgical Oncology, Vol. 14, Núm. 5, pp. 1744-1751

  4. Braquiterapia en el tratamiento del cáncer

    Jano: Medicina y humanidades, Núm. 1656, pp. 23-28

  5. Carcinoma microcítico de pulmón

    Revista de medicina, Vol. 51, Núm. 2, pp. 7-13

  6. Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer

    Expert Opinion on Biological Therapy, Vol. 7, Núm. 5, pp. 599-615

  7. Combining chemotherapy and targeted therapies in metastatic colorectal cancer

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5867-5876

  8. Células madre y cáncer: dilucidando el origen de la célula madre tumoral

    Revista de medicina, Vol. 51, Núm. 2, pp. 14-17

  9. Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Núm. 9, pp. 1396-1405

  10. Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What's new?

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5877-5887

  11. High-dose-rate brachytherapy in lower eyelid cancer

    Brachytherapy, Vol. 6, Núm. 3, pp. 227-229

  12. Immunotherapy and immunoescape in colorectal cancer

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5822-5831

  13. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer

    Brachytherapy, Vol. 6, Núm. 3, pp. 195-200

  14. Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients

    Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 323-328

  15. Molecular biology of cervical cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 347-354

  16. Nuevos tratamientos para el carcinoma renal

    Anales del sistema sanitario de Navarra, Vol. 30, Núm. 3, pp. 393-403

  17. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)

    Leukemia and Lymphoma, Vol. 48, Núm. 12, pp. 2461-2464

  18. Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors

    Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 11, pp. 1324-1337

  19. Phase II trial: Concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck

    Clinical and Translational Oncology, Vol. 9, Núm. 4, pp. 244-250

  20. Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer

    Oncology Reports, Vol. 17, Núm. 2, pp. 325-328